Proto-oncogene C-crk
Mus musculus
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Protein monomer Monomer Protein × 1 PDB declaration: monomeric(1) Consistent with protein copy count | Chain A; UniProt 132–191 | Fragment:N-TERMINAL SH3 DOMAIN (residues 132-191) Mutation:R191G, added G133, C132 | No other associated polymer | SOLUTION NMR NMR measurement conditions:pH 7.2;307 K;Ionic strength (raw mmCIF value) 100 mM NaCl;Pressure ambient NMR sample composition:1mM SH3 NA, 20mM sodium phosphate, 20 mM DTT-d10, 100 mM NaCl, 0.1% (w/v) NaN3 | 90% H2O/10% D2O NMR sample composition:1mM SH3 U-15N, 20mM sodium phosphate, 20 mM DTT-d10, 100 mM NaCl, 0.1% (w/v) NaN3 | 90% H2O/10% D2O | Resolution not provided |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 1M3C | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 1B07 CRK SH3 DOMAIN COMPLEXED WITH PEPTOID INHIBITOR Deposited 1998-11-17 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
134–190(57 aa)
Fragment:SH3 DOMAIN
|
Not recorded | PYJ PHENYLETHANE × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6;29% PEG4000, 0.2 M AMMONIUM ACETATE, PH 6.0, pH 6.00
|
Resolution 2.50 Å R-free 0.354 |
| 1CKA STRUCTURAL BASIS FOR THE SPECIFIC INTERACTION OF LYSINE-CONTAINING PROLINE-RICH PEPTIDES WITH THE N-TERMINAL SH3 DOMAIN OF C-CRK Deposited 1995-01-24 | Different construct Different mutation/modification Different oligomeric state Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
134–190(57 aa)
|
Not recorded | No recorded non-water small molecule | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 1.50 Å |
| 1CKB STRUCTURAL BASIS FOR THE SPECIFIC INTERACTION OF LYSINE-CONTAINING PROLINE-RICH PEPTIDES WITH THE N-TERMINAL SH3 DOMAIN OF C-CRK Deposited 1995-01-24 | Different construct Different mutation/modification Different oligomeric state Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
134–190(57 aa)
|
Not recorded | No recorded non-water small molecule | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 1.90 Å |
| 1JU5 Ternary complex of an Crk SH2 domain, Crk-derived phophopeptide, and Abl SH3 domain by NMR spectroscopy Deposited 2001-08-23 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions | Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain B
217–228(12 aa)
Fragment:Crk phosphopeptide
|
Non-standard monomer:Yes (specific site not provided by mmCIF) | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 6.8;303 K;Ionic strength (raw mmCIF value) 50mM sodium phosphate;Pressure ambient
NMR sample composition
0.6-1.5mM Crk SH2 domain U-15N, 13C; 50mM sodium phosphate pH6.8, 0.02% sodium azide | 90% H2O/10% D2O
|
Resolution not provided |
| 1M30 Solution structure of N-terminal SH3 domain from oncogene protein c-Crk Deposited 2002-06-26 | Different construct Different mutation/modification | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
134–191(58 aa)
Fragment:N-TERMINAL SH3 DOMAIN (residues 134-191)
|
Mutation:R191G | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 7.2;307 K;Ionic strength (raw mmCIF value) 100 mM NaCl;Pressure ambient
NMR sample composition
1mM SH3 NA, 20mM sodium phosphate, 20 mM DTT-d10, 100 mM NaCl, 0.1% (w/v) NaN3 | 90% H2O/10% D2O
NMR sample composition
1mM SH3 U-15N, 20mM sodium phosphate, 20 mM DTT-d10, 100 mM NaCl, 0.1% (w/v) NaN3 | 90% H2O/10% D2O
|
Resolution not provided |
| 1M3A Solution structure of a circular form of the truncated N-terminal SH3 domain from oncogene protein c-Crk. Deposited 2002-06-27 | Different construct Different mutation/modification | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
135–191(57 aa)
Fragment:N-TERMINAL SH3 DOMAIN (residues 135-191)
|
Mutation:R191G, E135C, deleted A134 | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 7.2;307 K;Ionic strength (raw mmCIF value) 100 mM NaCl;Pressure ambient
NMR sample composition
1mM SH3 NA, 20mM sodium phosphate, 20 mM DTT-d10, 100 mM NaCl, 0.1% (w/v) NaN3 | 90% H2O/10% D2O
NMR sample composition
1mM SH3 U-15N, 20mM sodium phosphate, 20 mM DTT-d10, 100 mM NaCl, 0.1% (w/v) NaN3 | 90% H2O/10% D2O
|
Resolution not provided |
| 1M3B Solution structure of a circular form of the N-terminal SH3 domain (A134C, E135G, R191G mutant) from oncogene protein c-Crk. Deposited 2002-06-27 | Different construct Different mutation/modification | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
134–191(58 aa)
Fragment:N-TERMINAL SH3 DOMAIN (residues 134-191)
|
Mutation:R191G, E135G, A134C | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 7.2;307 K;Ionic strength (raw mmCIF value) 100 mM NaCl;Pressure ambient
NMR sample composition
1mM SH3 NA, 20mM sodium phosphate, 20 mM DTT-d10, 100 mM NaCl, 0.1% (w/v) NaN3 | 90% H2O/10% D2O
NMR sample composition
1mM SH3 U-15N, 20mM sodium phosphate, 20 mM DTT-d10, 100 mM NaCl, 0.1% (w/v) NaN3 | 90% H2O/10% D2O
|
Resolution not provided |
| 2GGR Solution structure of the C-terminal SH3 domain of c-CrkII Deposited 2006-03-24 | Different construct Different mutation/modification Different experimental conditions | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
230–304(75 aa)
Fragment:C-terminal Domain
|
Not recorded | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 7.2;298 K;Ionic strength (raw mmCIF value) 50mM;Pressure ambient
NMR sample composition
0.4 mM cSH3 domain U-15N,13C; 10mM phosphate buffer pH7.2; 50mM NaCl; 5mM DTT-d10; 0.1% NaN3; 1mM EDTA; 90% H2O, 10% D2O | 90% H2O/10% D2O
|
Resolution not provided |
| 5IH2 Structure, thermodynamics, and the role of conformational dynamics in the interactions between the N-terminal SH3 domain of CrkII and proline-rich motifs in cAbl Deposited 2016-02-28 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
134–191(58 aa)
Fragment:UNP residues 134-191
|
Not recorded | PEG DI(HYDROXYETHYL)ETHER × 1 NA SODIUM ION × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K
|
Resolution 1.80 Å R-free 0.243 |
| 5IH2 Structure, thermodynamics, and the role of conformational dynamics in the interactions between the N-terminal SH3 domain of CrkII and proline-rich motifs in cAbl Deposited 2016-02-28 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
134–191(58 aa)
Fragment:UNP residues 134-191
|
Not recorded | NA SODIUM ION × 1 P4G 1-ETHOXY-2-(2-ETHOXYETHOXY)ETHANE × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K
|
Resolution 1.80 Å R-free 0.243 |
| 5JN0 CRK-II SH2 domain Deposited 2016-04-29 | Different construct Different mutation/modification Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
6–121(116 aa)
Fragment:UNP residues 6-121
|
Not recorded | CL CHLORIDE ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;297 K;100 mM MES pH 6.5, 12% PEG 20,000
|
Resolution 1.68 Å R-free 0.210 |
| 5L23 Crystal structure of the complex between the N-terminal SH3 domain of CrkII and a proline-rich ligand Deposited 2016-07-30 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
134–191(58 aa)
Fragment:UNP residues 134-191
|
Not recorded | PEG DI(HYDROXYETHYL)ETHER × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;286 K;Lithium sulfate monohydrate, PEG 3350
|
Resolution 1.77 Å R-free 0.210 |
11 other PDB entries and 12 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | CRK_MOUSE |
| Isoform | — |
| PDB entities | 1 |
| Chains and sequence ranges | Author chain A; PDBConstruct 1–60; UniProt 132–191 |